35.06 USD
+0.27 (+0.78%)
35.06 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to MRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 50.09. This target is 42.88% above the current price.
MRX was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MRX.
In the previous month the buy percentage consensus was at a similar level.
MRX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-16 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-03 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-20 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-12-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-21 | HSBC | Initiate | Buy |
| 2024-11-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-06 | Citigroup | Reiterate | Buy -> Buy |
| 2024-10-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-15 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-14 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-20 | Keefe, Bruyette & Woods | Initiate | Outperform |
| 2024-05-20 | UBS | Initiate | Buy |
| 2024-05-20 | Barclays | Initiate | Overweight |
| 2024-05-20 | Goldman Sachs | Initiate | Buy |
| 2024-05-20 | Piper Sandler | Initiate | Overweight |
| 2024-05-20 | Citigroup | Initiate | Buy |
MAREX GROUP PLC / MRX FAQ
Can you provide the average price target for MAREX GROUP PLC stock?
13 analysts have analysed MRX and the average price target is 50.09 USD. This implies a price increase of 42.88% is expected in the next year compared to the current price of 35.06.
What is the consensus rating for MAREX GROUP PLC (MRX) stock?
The consensus rating for MAREX GROUP PLC (MRX) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for MAREX GROUP PLC stock?
The number of analysts covering MAREX GROUP PLC (MRX) is 13.